E-drug: One World Health and DNDi (cont'd)
-------------------------------------------------------------------------
Both IOWH and DNDi are not-for-profit organisations committed to
researching and developing drugs for neglected diseases, such as
malaria, leishmaniasis, human African trypanosomiasis, and Chagas
disease, that affect the poorer populations in tropical countries. Both
organisations have analysed the crisis in lack of drugs for these
diseases -- the former from the perspective of research scientists and
the latter from the perspective of doctors in the field. Both
organisations have concluded that the need for new drugs for these
diseases is great and are aiming to meet this need.
IOWH is a US-based private organisation. DNDi is an international
initiative whose founding group comprises four public medical
research organisations (the Brazilian Fiocruz, the Indian Council for
Medical Research, the Malaysian Ministry of Health, and the Kenya
Medical Research Insitute representing a wider AfricaDNDi network),
the French Institut Pasteur, and the humanitarian medical aid
organisation Medecins Sans Frontieres / Doctors without Borders,
with WHO/TDR on board as a permanent observer.
The problem is vast and its resolution needs more collaborative
initiatives such as IOWH and DNDi working towards developing new
treatments for neglected diseases.
Jaya Banerji
Communications & Advocacy
Drugs for Neglected Diseases Initiative (DNDi)
12 Rue du Lac
Case Postale 6090
CH1211 Geneva 6
Switzerland
Tel: +41 22 849 8405
e-mail: jaya.banerji@geneva.msf.org
www.dndi.org
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug